Rechercher | Friends - Best Social Network - החברים - רשת חברתית

Commandité

Rechercher

John Snow @johnsnow Ajouter une nouvelle offre d'emploi in Health
2025-09-22 17:16:36

CDI Treatment Evolution: Antibiotics, Biotherapeutics, and Vaccines Shaping the Future

A Decade of Change in Clostridioides difficile Management For years, the primary approach to managing Clostridioides difficile infections (CDI) relied on vancomycin and metronidazole (Flagyl). Limitations such as recurrence and emerging resistance became increasingly apparent. The introduction of fidaxomicin (Dificid) offered a more targeted therapy, sparking clinical comparisons like Zinplava...

0 Commentaires ·0 Parts ·246 Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Devidi Jahnavi @ciinsights Ajouter une nouvelle offre d'emploi in Health
2025-07-08 05:15:06

Emerging Vaccines for Ebola: Global Market Overview

What is the projected growth rate (CAGR) of the Ebola *** Vaccine Market from 2024 to 2031, and what is the market value expected to change by 2031? The Global Ebola *** Vaccine Market reached US$173.82 million in 2024 and is expected to reach US$288.41 million by 2033, growing at a CAGR of 6.4 % during the forecast period 2025-2033. What is the Ebola *** Vaccine Market? The Ebola *** Vaccine...

0 Commentaires ·0 Parts ·1KB Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Devidi Jahnavi @ciinsights Ajouter une nouvelle offre d'emploi in Health
2025-07-08 07:47:15

Global Demand for Inactivated Vaccines: Trends and Insights

What is the projected growth rate (CAGR) of the Inactivated Vaccines Market from 2024 to 2031, and what is the market value expected to change by 2031? The Global Inactivated Vaccines Market reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032. What is the Inactivated Vaccines Market? This market...

0 Commentaires ·0 Parts ·1KB Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!
John Snow @johnsnow Ajouter une nouvelle offre d'emploi in Health
2025-09-20 18:34:37

Harnessing mRNA Technology: Transforming Vaccines and Therapeutic Innovations

The emergence of mRNA-based vaccines has revolutionized global healthcare by demonstrating rapid adaptability and effective immune response. Unlike conventional vaccines, these therapies instruct cells to produce antigens, triggering immunity without using live pathogens. This breakthrough has positioned mRNA therapies as a transformative force in the vaccines and therapeutics landscape....

0 Commentaires ·0 Parts ·265 Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Sindhuri Kotamraju @sindhu Ajouter une nouvelle offre d'emploi in Health
2025-07-18 11:37:11

Inactivated Vaccines Market Share and Future Scope

“Global Inactivated Vaccines Market reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032”, according to DataM intelligence report. Inactivated vaccines are created by *** the disease-causing microorganisms using heat, chemicals, or radiation. Unlike live vaccines, these do not...

0 Commentaires ·0 Parts ·1KB Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Sindhuri Kotamraju @sindhu Ajouter une nouvelle offre d'emploi in Health
2025-08-29 09:40:43

Live Attenuated Vaccines Market Report | CAGR 6.6% Driven by Preventive Healthcare Awareness & Key Growth Segments

The live attenuated vaccines market plays a pivotal role in global immunization strategies. By leveraging weakened pathogens viral or bacterial to induce robust and durable immune responses, these vaccines provide advantages like long-term protection with fewer doses. They are vital in fighting diseases such as measles, oral polio, rotavirus, tuberculosis, yellow fever, and some less common...

0 Commentaires ·0 Parts ·300 Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Devidi Jahnavi @ciinsights Ajouter une nouvelle offre d'emploi in Health
2025-06-23 12:17:24

mRNA Vaccines Redefined: CI Insights into Innovation, Platforms, and Market Expansion

Messenger RNA (mRNA) vaccines have emerged as a transformative force in the global fight against infectious diseases, with their rapid development, adaptability, and precision mechanism driving a new era of preventive medicine. Once considered experimental, mRNA technology now stands at the forefront of vaccine innovation, with expanding applications in infectious disease, oncology, and...

0 Commentaires ·0 Parts ·2KB Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Uttej Netha @marketresearch Ajouter une nouvelle offre d'emploi in Health
2025-06-27 09:45:32

USDA’s Poultry Vaccine Plan Accelerates USD 12B+ Veterinary Vaccines Industry

The global veterinary vaccines market is entering a phase of sustained growth and innovation, with mounting demand from both companion animal and livestock sectors. According to recent data, market valuation reached USD 12.05 billion in 2024 and is forecast to climb to USD 12.51 billion in 2025 and USD ***56 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.8%. Meanwhile,...

0 Commentaires ·0 Parts ·2KB Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Tejask Kam @tejaskam Ajouter une nouvelle offre d'emploi in Autre
2025-10-12 17:37:44

Veterinary Vaccines Market Size & Global Trends Forecast Report by 2025

According to Straits Research the global veterinary vaccines market size was valued at USD 12.32 billion in 2024 and is expected to reach USD 22.54 billion in 2033, growing at a CAGR of 6.94% during the forecast period (2025–2033). The central objective of this study is to define and quantify the global Veterinary Vaccines market...

0 Commentaires ·0 Parts ·99 Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Emma Stone @es0314987 Ajouter une nouvelle offre d'emploi in Networking
2025-08-02 16:21:02

Viral Vector Vaccines Market to Surpass USD 2.6 Billion by 2032: Key Players, Segments, and Growth Forecast

The global Viral Vector Vaccines Market was valued at USD 850.43 million in 2024 and is expected to grow at a CAGR of 15.93% between 2025 and 2032. Fueled by rising infectious disease prevalence and innovations in genetic engineering, viral vector vaccines have become critical tools in modern immunology. According to a recent report by AnalystView Market Insights (Report Code: AV4115), this...

0 Commentaires ·0 Parts ·933 Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Kranthi Reddy @kranthireddypalla Ajouter une nouvelle offre d'emploi in Health
2025-06-20 12:27:20

Global Immunization Growth Powers Live Attenuated Vaccine Demand

The Live Attenuated Vaccines Market is experiencing rapid expansion, projected to grow from USD 25.3 billion in 2023 to USD 70.4 billion by 2032. The market is driven by increased demand for robust, long-lasting immunizations, innovations in oral and intranasal delivery systems, and rising infectious disease threats worldwide. Growth is especially strong in the United States, Japan, and across...

0 Commentaires ·0 Parts ·2KB Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!
Uttej Netha @marketresearch Ajouter une nouvelle offre d'emploi in Health
2025-06-30 07:33:24

Screening & Awareness Initiatives Bolster Hepatitis B *** Uptake

The global Hepatitis B Treatment Market is positioned for consistent growth, with market valuation expected to increase from USD 4.5 billion in 2023 to USD 7.3 billion by 2032, growing at a CAGR of 5.9% during the forecast period (2024–2032). The rise in chronic hepatitis B cases globally, combined with growing awareness, treatment accessibility, and a strong pipeline of advanced...

0 Commentaires ·0 Parts ·2KB Vue ·0 Aperçu

Connectez-vous pour aimer, partager et commenter!

Plus de résultats

Mise à niveau vers Pro

Choisissez le forfait qui vous convient

Commandité